•The literature was reviewed so as to develop practical recommendations regarding the use of medical adhesives for hospitalized newborns.•Four perspectives were identified regarding the application ...and removal of adhesives, skin condition assessment, use of adhesives as a platform, and discouraging the use of adhesives as a skin barrier.•Additional studies are needed to precisely determine the criteria for choosing adhesives and the effectiveness of the preventive measures implemented to preserve skin integrity.
The skin is the largest organ in the human body. It provides multiple barrier functions, tactile or defensive, and acts as a mediator allowing for the attachment of vital monitoring devices with medical adhesives. Adhesives consist of several layers with varying compositions and properties. We aimed to provide recommendations for their use in the care of hospitalized neonates on the basis of a systematic literature review.
We searched PubMed for English or French articles published before May 29, 2020, using the keywords “adhesive,” “tape,”, “skin,” and “neonat*.” Recommendations were developed after review by a multidisciplinary group including 15 professionals and parent representatives.
We identified 295 studies, and from 30 eligible studies we developed six recommendations according to four perspectives: assessment of the skin condition to improve the methods of application of the different adhesives and their removal; use of adhesives as a platform; and discouraging the regular use of semi-permeable dressings to compensate for the immaturity of the skin barrier.
Skin lesions are common for hospitalized neonates. Use of adhesives may increase the occurrence of such lesions. Adhesives should be subject to good clinical practice guidelines. Health professionals caring for newborns should know the tools for screening and preventing skin lesions.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP
Summary
Burguet A, Ferdynus C, Thiriez G, Bouthet M‐F, Kayemba‐Kays S, Sanyas P, Menget A, Mulin B, Riethmuller D, Maillet R, Brousse C, Magnin G, Boisselier P, Sagot P, Pierre F, Gouyon B, Gouyon ...J‐B. Very preterm birth: who has access to antenatal corticosteroid therapy? Paediatric and Perinatal Epidemiology 2010; 24: 63–74.
We describe the administration of antenatal corticosteroid therapy (ACT) for liveborn very preterm neonates in a population‐based study. A total of 790 very preterm neonates (between 24 and 31 full weeks of gestation) were included in this regionally defined population of very preterm neonates in France. The main outcome measure was non‐access to ACT. Data were analysed using logistic and polytomous models to control for neonatal and sociodemographic characteristics, mechanisms of very preterm birth and neonatal network organisation.
As compared with level III, births in levels I‐II maternity units were closely related to non‐access to ACT (60.1% vs. 8.8%), but not to pregnancy follow‐up (19.7% vs. 17.8%). Only 6.3% of very preterm neonates that benefited from antepartum referral did nor receive ACT. Births associated with rupture of membranes and gestational hypertension were significantly more often transferred to level‐III units (73.8% and 68.3% respectively) than those due to maternal bleeding and spontaneous labour (57.0% and 50.7% respectively), and the neonates had a lower probability of not receiving ACT (8.5%, 11.5%, 23.0%, 31.2% respectively). Very preterm neonates referred in utero to a level‐III unit came from a more favourable socio‐economic environment. Non‐access to ACT was more often observed in neonates born to 14‐ to 24‐year‐old mothers, smokers, of low socio‐economic status, and preterm birth resulting from maternal bleeding or spontaneous labour.
These data from a French regional study show that access to ACT is not only explained by practitioners' support of recommendations. In our population‐based study, ACT access was related to socio‐economic factors and to the mechanisms of very preterm birth. Improving the rate of access to ACT should take these organisational, medical and socio‐economic dimensions into account.
Full text
Available for:
BFBNIB, DOBA, FZAB, GIS, IJS, IZUM, KILJ, NLZOH, NUK, OILJ, PILJ, PNG, SAZU, SBCE, SBMB, SIK, UILJ, UKNU, UL, UM, UPUK
34.
44 Cytostéatonécrose et hypercalcémie néonatale Karim, Jamal-Bey; Claire, Bosset; Nawel, Afroukh ...
Journal de gynécologie, obstétrique et biologie de la reproduction,
5/2005, Volume:
34, Issue:
3
Journal Article
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
Load filters
No result was selected!
Please select the results that you wish to export.
The search was successfully saved.
Editing
The search could not be saved.
Saved searches can be viewed in the list My searches.
The changes made to the saved search were saved successfully.
Save search
Shelf entry
No result was selected!
Adding material to shelf was successful.
Adding material to shelf was partly successful.
Adding material to shelf failed completely.
It was not necessary to add the material to the shelf.
Please select the results that you want to put on shelf!
On shelf the following records have been successfully added:
On shelf the following records have been successfully added:
